TrialBMC pediatrics2014

The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.

Peter A Dargaville et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.